Gufic Biosciences Limited (BOM:509079)
India · Delayed Price · Currency is INR 287.10
-5.25 (-1.80%)
At close: May 5, 2026
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 29.38 billion as of May 6, 2026. Its market cap has decreased by -11.26% in one year.
Market Cap
29.38B
Enterprise Value
32.19B
Revenue
8.97B
Ranking
n/a
PE Ratio
58.75
Stock Price
287.10
Market Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 29.38B, an increase of 8,127.34%. That is a compound annual growth rate of 19.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 28.79B | -14.74% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FDC Limited | 59.38B |
| Bliss GVS Pharma | 29.22B |
| Unichem Laboratories | 27.41B |
| Novartis India | 25.50B |
| Hikal | 23.41B |
| Morepen Laboratories | 22.69B |
| Amrutanjan Health Care | 16.49B |
| Kwality Pharmaceuticals | 16.41B |